Skip to content

Agenda

6:30 – 7:30 am Registration Check-In & Breakfast
7:30 – 7:45 am Welcome & Chairman’s Opening Remarks
Followed By “2014 Year In Review”
7:45 – 9:37 am BioPharma Company Showcase
Co-Moderated By:
Robert Dempsey, Vice President & Business Unit Head – Shire Ophthalmics
Calvin W. Roberts, MD, Executive Vice President & CMO – Bausch + Lomb

7:45-7:53 – Allysta Pharmaceuticals – Henry Hsu, MD, Founder & CEO
7:53-8:01 – Aerie Pharmaceuticals – Vicente Anido Jr., PhD, CEO
8:01-8:09 – ONL Therapeutics – John Freshley, CEO
8:09-8:17 – Kala Pharmaceuticals – Charlie McDermott, Interim President & CBO
8:17-8:25 – MC2 Biotek Group – Jesper J. Lange, President & Co-Founder
8:25-8:33 – Novaliq GmbH – Bernhard Gunther, CEO
8:33-8:41 – Mobius Therapeutics – Ed Timm, President & CEO
8:41-8:49 – GrayBug – Michael O’Rourke, President & CEO
8:49-8:57 – Avalanche Biotechnologies – Thomas W. Chalberg, PhD, Founder & CEO
8:57-9:05 – Allegro Ophthalmics – Vicken Karageozian, MD, Co-Founder & CTO
9:05-9:13 – Translatum Medicus – Shelley Boyd, MD, FRCSC, President & CSO
9:13-9:21 – Ophthotech – David R. Guyer, MD, CEO
9:21-9:29 – Panoptes – Franz Obermayr, PhD, Co-Founder & CEO
9:29-9:37 – XOMA Corporation – Paul Rubin, MD, CMO

9:37 – 10:07 am Networking Break
Sponsored By:
Santen
10:07 – 11:51 am Device, Delivery, & Diagnostic Company Showcase
Co-Moderated By:
Laurent Attias, Head, Global Commercial Strategy – Alcon
Jane Rady, Divisional Vice President, Business Development – Abbott Medical Optics

10:07-10:15 – TearScience – Tim Willis, CEO & Co-Founder
10:15-10:23 – WaveTec Vision Systems – Thomas G. Frinzi, President & CEO
10:23-10:31 – PowerVision – Barry Cheskin, President & CEO
10:31-10:39 – Avedro – David Muller, PhD, President & CEO
10:39-10:47 – Implandata Ophthalmic Products GmbH – Max G. Ostermeier, MBA, Co-Founder & General Manager
10:47-10:55 – InnFocus – Russell Trenary, President & CEO
10:55-11:03 – IOPtima – Ronen Castro, CEO
11:03-11:11 – i-Optics – Jeroen Cammeraat, CEO
11:11-11:19 – Neurotech – Quinton Oswald, President & CEO
11:19-11:27 – ForSight VISION5 – John Maroney, CEO
11:27-11:35 – Mati Therapeutics – Robert Butchofsky, Founder & CEO
11:35-11:43 – Ocular Therapeutix – Amarpreet Sawhney, PhD, President & CEO
11:43-11:51 – Alimera Sciences – Dan Myers, President & CEO

11:51 am – 12:21 pm Digital Ophthalmology Showcase
Moderated By:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners

11:51-11:56 – CheckedUp – Richard M. Awdeh, MD, Founder & CEO
11:56-12:01 – Gobiquity – Michael Brownell, CEO
12:01-12:06 – DigiSight – Doug Foster, CEO
12:06-12:11 – Vestrum Health – Tom Brogan, Chairman of the Board
12:11-12:16 – AppVisit – Harvey Fishman, MD, PhD, Co-Founder & Medical Director
12:16-12:21 – Assort – Noel Alpins, MD, FACS, CEO

12:21 – 12:41 pm Digital Ophthalmology
The Alcon/Google Partnership & Beyond
Panelists:
Laurent Attias, Head, Global Commercial Strategy – Alcon
Franck Leveiller, PhD, VP, Head of Research & Development Vision Care – Alcon
Brian P. Otis, PhD, Founder, Smart Contact Lens Project – Google X

Moderated By:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners

12:41 pm Lunch Commences
1:10 – 1:35 pm Plenary Keynote: Accelerating Innovation In Ophthalmology
Jeff George, President & Global Head – Alcon
1:35 – 2:00 pm OIS Innovator Award Presentation
2:00 pm Luncheon Concludes
2:00 – 2:07 pm Ophthalmic Innovation 2014
A View From The AAO
David W. Parke, MD, CEO – American Academy of Ophthalmology
2:07 – 2:15 pm Ophthalmic Innovation 2014
A View From The NEI
Matthew J. McMahon, PhD, Director, Office of Translational Research, National Eye Institute – National Institutes of Health
2:15 – 2:20 pm Houston, We Have A Problem
Visual Disorders In Space And How Ophthalmology Can help
Dorit B. Donoviel, PhD, Deputy Chief Scientist & Industry Forum Lead – National Space Biomedical Research Institute
2:20 – 2:50 pm FDA Q&A
Panelists:
Wiley A. Chambers, MD, Supervisory Medical Officer, Division of Transplant & Ophthalmology Products – FDA
Malvina B. Eydelman, MD, Director, Division of Ophthalmic Device Evaluation – FDA

Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures

2:50 – 3:20 pm Second Acts – Reinventing Your Company
Panelists:
Vicente Anido Jr., PhD, CEO – Aerie Pharmaceuticals
Mark Forchette, Former CEO – OptiMedica
Thomas G. Frinzi, President & CEO – WaveTec Vision Systems
Stuart Abelson, President & CEO – Ora
Ron Kurtz, MD, Founder – Intralase

Moderated By:
William J. Link, PhD, Managing Director – Versant Ventures

3:20 – 3:50 pm Afternoon Refreshment & Networking Break
Sponsored By:
Santen
3:50 – 4:00 pm Private Funding Trends Presentation
Jonathan Norris, Managing Director – SVB
4:00 – 4:10 pm The Ophthalmology Market
A View Of The Public Sector & Exit Trends
Jeffrey Hoffman, Managing Director & Head of West Coast Healthcare Investment Banking – J.P. Morgan
4:10 – 4:40 pm IPOs In Ophthalmology – The Class Of 2014 & Beyond
Panelists:
Susan Washer, President & CEO – AGTC
Amarpreet Sawhney, PhD, President & CEO – Ocular Therapeutix
Vicente Anido Jr., PhD, CEO – Aerie Pharmaceuticals
Brian Johnson, Partner – WilmerHale
Thomas W. Chalberg, PhD, Founder & CEO – Avalanche Biotechnologies
Michael Gaito, Managing Director – Head of West Coast Life Sciences – J.P. Morgan

Moderated By:
David R. Guyer, MD, CEO – Ophthotech

4:40 – 5:10 pm Industry Consolidation: The Good, The Bad And The Unknown
Panelists:
Jeff George, President & Global Head – Alcon
David E.I. Pyott, CEO – Allergan
Murthy V. Simhambhatla, PhD, President – Abbott Medical Optics
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
William J. Link, PhD, Managing Director – Versant Ventures

Moderated By:
James Mazzo, Chairman & CEO – AcuFocus

5:10 pm Wrap-Up & Closing Comments
5:10 – 6:30 pm Cocktail Reception
Scroll To Top